Evidence map›Paper›PMID 34155317›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2021

Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.

Judith Martha Neumann, Karsten Niehaus, Nils Neumann, Hans Christoph Knobloch, Felix Bremmer, Ulrich Krafft, Udo Kellner, Peter Nyirády, Tibor Szarvas, Hanna Bednarz and 1 more

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Judith Martha NeumannProteome and Metabolome Research, Center for Biotechnology (CeBiTec), Faculty of Biology, Bielefeld University, Bielefeld, Germany.ORCID 0000-0002-5638-8548
Karsten NiehausProteome and Metabolome Research, Center for Biotechnology (CeBiTec), Faculty of Biology, Bielefeld University, Bielefeld, Germany.
Nils NeumannResearch Institute for Cognition and Robotics (CoR-Lab), Bielefeld University, Bielefeld, Germany.
Hans Christoph KnoblochDepartment of Urology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
Felix BremmerInstitute of Pathology, University Medical Center Göttingen, University of Göttingen, Göttingen, Germany.
Ulrich KrafftDepartment of Urology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Udo KellnerInstitut für Pathologie, Johannes Wesling Klinikum Minden, Minden, Germany.
Peter NyirádyDepartment of Urology, Semmelweis University Budapest, Budapest, Hungary.
Tibor SzarvasDepartment of Urology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Hanna BednarzProteome and Metabolome Research, Center for Biotechnology (CeBiTec), Faculty of Biology, Bielefeld University, Bielefeld, Germany. hanna.bednarz@uni-bielefeld.de.
Henning ReisInstitute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. henning.reis@uk-essen.de.
Bielefeld University · DESemmelweis University · HUUniversitätsmedizin Göttingen · DEUniversity of Duisburg-Essen · DEJohannes Wesling Klinikum Minden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34155317
PMCPMC8440205
OpenAlexW4233537271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.